It mediates noncanonical STING activation, inducing NF‐κB signaling in HER2+ bc [73, 74], while its knockout suppresses ESCC proliferation, IL‐1α secretion, and tumor progression [75, 76]. Here, ERBB2 is linked to neoplasm.